Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

In a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator’s subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial mode” for its use and making it a case of regular emergency use authorisation., In a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator’s subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial mode” for its use and making it a case of regular emergency use authorisation., , Read More